The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Deepak Reddy B & PACs
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved in line with Nifty Microcap 250 and 0.7 pts more than its Healthcare Service Provider peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Promoter Deepak Reddy B along with PACs (Prajitha Bandaram, Satyavathi Bandaram, B Premsai Reddy, L. Lalanthika, M. Seetharama Reddy, and M. Sukumari) have acquired additional equity shares of Bandaram Pharma Packtech Ltd through a preferential allotment on 06.11.2025. A total of 22,54,484 shares (12.54% of pre-allotment capital) were subscribed to, with Deepak Reddy B taking the largest chunk at 16,07,996 shares. As a result, the promoter group's combined holding rose from 90,00,000 shares to 1,12,54,484 shares, although their percentage holding came down from 75.00% to 62.62% due to dilution from new shares issued to non-promoters as well. The company's total equity capital expanded from Rs. 12.00 crore (1.2 crore shares) to Rs. 17.97 crore (1.797 crore shares) of Rs. 10 each.
This signals promoter confidence and a fresh capital infusion into the company via preferential issue. The promoter group's dominant 62.62% stake post-allotment leaves limited free float, which could keep the stock less liquid, while dilution from non-promoter allotments partially trims their control.